However, late-stage lung cancer patients showed a marked loss of KLF4 expression (p = 0.0486) and a significant association in the distribution of patients according to metastatic lymph nodes (p = 0.0063), suggesting that the loss of KLF4 expression might contribute to lung cancer progression. This evidence concerns the gene KLF4 and lung cancer.